Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014718258> ?p ?o ?g. }
- W2014718258 endingPage "373" @default.
- W2014718258 startingPage "369" @default.
- W2014718258 abstract "Objectives To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of pramlintide in treating adolescents with type 1 diabetes. Study design Twelve subjects (9 females, 3 males, age 12 to 17 years; A1C, 8.4%; body mass index, 25 kg/m2) were randomized to pramlintide (15 or 30 μg) or placebo administered before a standardized breakfast. Insulin lispro (50% of usual mealtime dose) was injected separately. Acetaminophen (1000 mg) was administered orally to provide an indicator of gastric emptying rate. Results In 9 evaluable subjects, plasma pramlintide concentrations increased dose-proportionately; mean peak plasma concentration (Cmax) (15-μg dose, 93 ± 9 pg/mL; 30-μg dose, 202 ± 21 pg/mL) occurred ∼0.3 h (median time to peak concentration) after administration. Pramlintide reduced incremental area under the concentration curve (AUC0-3h) for glucagon and glucose versus placebo (glucagon: 15-μg dose, 4 ± 7 pg∗h/mL; 30-μg dose, 5 ± 7 pg∗h/mL; placebo, 35 ± 9 pg∗h/mL; glucose: 15-μg dose, 129 ± 43 mg∗h/dL; 30-μg dose, 132 ± 37 mg∗h/dL; placebo, 217 ± 56 mg∗h/dL). Acetaminophen Cmax decreased with pramlintide; median Tmax was delayed by ∼2.6- to 3.8-fold. Pramlintide was well tolerated, and no treatment-related adverse events occurred. Conclusions Pramlintide reduced postprandial glucagon and glucose excursions and slowed gastric emptying in adolescents with type 1 diabetes, with no treatment-related adverse events. Long-term studies evaluating the efficacy and safety of pramlintide in adolescents are warranted. To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of pramlintide in treating adolescents with type 1 diabetes. Twelve subjects (9 females, 3 males, age 12 to 17 years; A1C, 8.4%; body mass index, 25 kg/m2) were randomized to pramlintide (15 or 30 μg) or placebo administered before a standardized breakfast. Insulin lispro (50% of usual mealtime dose) was injected separately. Acetaminophen (1000 mg) was administered orally to provide an indicator of gastric emptying rate. In 9 evaluable subjects, plasma pramlintide concentrations increased dose-proportionately; mean peak plasma concentration (Cmax) (15-μg dose, 93 ± 9 pg/mL; 30-μg dose, 202 ± 21 pg/mL) occurred ∼0.3 h (median time to peak concentration) after administration. Pramlintide reduced incremental area under the concentration curve (AUC0-3h) for glucagon and glucose versus placebo (glucagon: 15-μg dose, 4 ± 7 pg∗h/mL; 30-μg dose, 5 ± 7 pg∗h/mL; placebo, 35 ± 9 pg∗h/mL; glucose: 15-μg dose, 129 ± 43 mg∗h/dL; 30-μg dose, 132 ± 37 mg∗h/dL; placebo, 217 ± 56 mg∗h/dL). Acetaminophen Cmax decreased with pramlintide; median Tmax was delayed by ∼2.6- to 3.8-fold. Pramlintide was well tolerated, and no treatment-related adverse events occurred. Pramlintide reduced postprandial glucagon and glucose excursions and slowed gastric emptying in adolescents with type 1 diabetes, with no treatment-related adverse events. Long-term studies evaluating the efficacy and safety of pramlintide in adolescents are warranted." @default.
- W2014718258 created "2016-06-24" @default.
- W2014718258 creator A5039393797 @default.
- W2014718258 creator A5050877067 @default.
- W2014718258 creator A5070203517 @default.
- W2014718258 creator A5080256378 @default.
- W2014718258 creator A5081438827 @default.
- W2014718258 date "2009-09-01" @default.
- W2014718258 modified "2023-09-27" @default.
- W2014718258 title "Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study" @default.
- W2014718258 cites W1965367163 @default.
- W2014718258 cites W1965851116 @default.
- W2014718258 cites W1977763918 @default.
- W2014718258 cites W1982140340 @default.
- W2014718258 cites W1982298257 @default.
- W2014718258 cites W2010154622 @default.
- W2014718258 cites W2027916831 @default.
- W2014718258 cites W2045554373 @default.
- W2014718258 cites W2060927585 @default.
- W2014718258 cites W2061027504 @default.
- W2014718258 cites W2065786925 @default.
- W2014718258 cites W2066633683 @default.
- W2014718258 cites W2096129089 @default.
- W2014718258 cites W2126969411 @default.
- W2014718258 cites W2132648396 @default.
- W2014718258 cites W2139075957 @default.
- W2014718258 cites W2154314674 @default.
- W2014718258 cites W2326971529 @default.
- W2014718258 cites W2346484181 @default.
- W2014718258 cites W2769264260 @default.
- W2014718258 cites W52391068 @default.
- W2014718258 doi "https://doi.org/10.1016/j.jpeds.2009.03.012" @default.
- W2014718258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19464026" @default.
- W2014718258 hasPublicationYear "2009" @default.
- W2014718258 type Work @default.
- W2014718258 sameAs 2014718258 @default.
- W2014718258 citedByCount "32" @default.
- W2014718258 countsByYear W20147182582012 @default.
- W2014718258 countsByYear W20147182582013 @default.
- W2014718258 countsByYear W20147182582014 @default.
- W2014718258 countsByYear W20147182582015 @default.
- W2014718258 countsByYear W20147182582016 @default.
- W2014718258 countsByYear W20147182582017 @default.
- W2014718258 countsByYear W20147182582018 @default.
- W2014718258 countsByYear W20147182582022 @default.
- W2014718258 crossrefType "journal-article" @default.
- W2014718258 hasAuthorship W2014718258A5039393797 @default.
- W2014718258 hasAuthorship W2014718258A5050877067 @default.
- W2014718258 hasAuthorship W2014718258A5070203517 @default.
- W2014718258 hasAuthorship W2014718258A5080256378 @default.
- W2014718258 hasAuthorship W2014718258A5081438827 @default.
- W2014718258 hasConcept C111113717 @default.
- W2014718258 hasConcept C112705442 @default.
- W2014718258 hasConcept C126322002 @default.
- W2014718258 hasConcept C134018914 @default.
- W2014718258 hasConcept C142724271 @default.
- W2014718258 hasConcept C197934379 @default.
- W2014718258 hasConcept C204787440 @default.
- W2014718258 hasConcept C22979827 @default.
- W2014718258 hasConcept C27081682 @default.
- W2014718258 hasConcept C2777180221 @default.
- W2014718258 hasConcept C2778199505 @default.
- W2014718258 hasConcept C2778375690 @default.
- W2014718258 hasConcept C2778722691 @default.
- W2014718258 hasConcept C2779306644 @default.
- W2014718258 hasConcept C2779422922 @default.
- W2014718258 hasConcept C2781232474 @default.
- W2014718258 hasConcept C3020479747 @default.
- W2014718258 hasConcept C42219234 @default.
- W2014718258 hasConcept C555293320 @default.
- W2014718258 hasConcept C71924100 @default.
- W2014718258 hasConcept C87813604 @default.
- W2014718258 hasConcept C90924648 @default.
- W2014718258 hasConcept C98274493 @default.
- W2014718258 hasConceptScore W2014718258C111113717 @default.
- W2014718258 hasConceptScore W2014718258C112705442 @default.
- W2014718258 hasConceptScore W2014718258C126322002 @default.
- W2014718258 hasConceptScore W2014718258C134018914 @default.
- W2014718258 hasConceptScore W2014718258C142724271 @default.
- W2014718258 hasConceptScore W2014718258C197934379 @default.
- W2014718258 hasConceptScore W2014718258C204787440 @default.
- W2014718258 hasConceptScore W2014718258C22979827 @default.
- W2014718258 hasConceptScore W2014718258C27081682 @default.
- W2014718258 hasConceptScore W2014718258C2777180221 @default.
- W2014718258 hasConceptScore W2014718258C2778199505 @default.
- W2014718258 hasConceptScore W2014718258C2778375690 @default.
- W2014718258 hasConceptScore W2014718258C2778722691 @default.
- W2014718258 hasConceptScore W2014718258C2779306644 @default.
- W2014718258 hasConceptScore W2014718258C2779422922 @default.
- W2014718258 hasConceptScore W2014718258C2781232474 @default.
- W2014718258 hasConceptScore W2014718258C3020479747 @default.
- W2014718258 hasConceptScore W2014718258C42219234 @default.
- W2014718258 hasConceptScore W2014718258C555293320 @default.
- W2014718258 hasConceptScore W2014718258C71924100 @default.
- W2014718258 hasConceptScore W2014718258C87813604 @default.
- W2014718258 hasConceptScore W2014718258C90924648 @default.
- W2014718258 hasConceptScore W2014718258C98274493 @default.
- W2014718258 hasIssue "3" @default.